Point source concentration of GDNF may explain failure of phase II clinical trial

Michael F. Salvatore, Yi Ai, Brent Fischer, Amanda M. Zhang, Richard C. Grondin, Zhiming Zhang, Greg A. Gerhardt, Don M. Gash

Research output: Contribution to journalArticlepeer-review

225 Citations (SciVal)

Fingerprint

Dive into the research topics of 'Point source concentration of GDNF may explain failure of phase II clinical trial'. Together they form a unique fingerprint.

Neuroscience